Funny Jokes Collection at prettyjokes.com
With Viagra such a hit, Pfizer is bringing forth a whole line of
drugs oriented towards improving the performance of men in today’s
society.
DIRECTRA - A dose of this drug given to men before leaving on car
trips caused 72 percent of them to stop and ask for directions when
they got lost compared to a control group where only 0.2 percent
asked for directions.
PROJECTRA - Men given this experimental new drug were far more likely
to actually finish a household repair project before starting a new
one.
CHILDAGRA - Men taking this drug reported a sudden, overwhelming urge
to perform more child-care tasks, especially cleaning up spills and
little accidents.
COMPLIMENTRA - In clinical trials, 82 percent of middle-aged men
administered this drug noticed that their wives had a new hairstyle.
Currently being tested to see if its effects extend to noticing new
clothing.
BUYAGRA - Married and otherwise attached men reported a sudden urge
to buy their sweeties expensive jewelry and gifts after taking this
drug for only two days. Still to be seen: whether the drug can be
continued for a period longer than your favorite store’s return limit.
NEGA-VIAGRA - Has the exact opposite effect of Viagra. Currently
undergoing clinical trials on sitting U.S. presidents.
NEGA-SPORTAGRA - This drug had the strange effect of making men want
to turn off televised sports and actually converse with other family
members.
CAPAGRA - Caused test subjects to become uncharacteristically
fastidious about lowering toilet seats and replacing toothpaste
caps. Subjects on higher doses were seen dusting furniture.
PRYAGRA - About to fail its clinical trial, this drug gave men in
the test group an irresistible urge to dig into the personal affairs
of other people. Note: Apparent overdose turned three test subjects
into special prosecutors.
LIAGRA - This drug causes men to be less than truthful when they are
asked about their sexual affairs. Will be available in Regular,
Grand Jury and Presidential Strength versions.
Leave a reply